Support The Show On Patreon!:
Subscribe to Krystal Kyle & Friends On Substack!:
Vancouver-based MYND Life Sciences is exploring whether depression and other central nervous system disorders can be treated with novel psychedelic drugs, including psilocybin.
In January, the company announced a collaborative research agreement with the University of British Columbia on major depressive disorder.
Follow Kyle on Twitter:
Tweets by KyleKulinski